chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue and lightheaded within 3 hours of vaccine, lasted 3 full days. Headache within 12 hours of vaccine, lasted 24 hours. Muscle aches and restless legs within 18 hours of vaccine, lasted 36 hours. Dizziness within 24 hours of vaccine, lasted 72 hours. Mental fog within 3 hours of vaccine, lasted 36 hours.
A non-serious spontaneous report of FLUMIST administration to a pregnant female was received from a MedImmune Representative concerning a 30-year-old female. The patient's medical history, obstetrical history and concomitant medications were not reported. On 01-Jan-2006, the patient received FLUMIST. She was in her first trimester of pregnancy, however she was unaware that she was pregnant when she received FLUMIST. On an unknown date, she delivered a healthy, full-term, female. According to the reporter, no adverse events occurred.
Reported sudden "fast heartbeats with mild chest pain" lasted less than 2 mins with tingling of L arm where she received the injection. Stable, released from vaccination site.
This spontaneous report as received from a medical assistant refers to a patient of unknown age (gender not reported). On 17-APR-2013 the patient was vaccinated with an expired dose of GARDASIL (1397AA; expiry date 09-APR-2013) as the third dose in the GARDASIL vaccination series. Dose 3, GARDASIL was vaccinated intramuscularly. No adverse effect reported. Additional information has been requested.
I take FLU shots each year without incident.  I've had MS since 1998.  I just got the flu shot and pneumonia shot yesterday (dead virus)  I became ill within the hour and went to bed.  I woke up about 2 hours later with no voluntary movement except my head.  That's right.  Total body paralysis below my neck.  I slowly began to achieve some movement.  But, this was accompanied by violent total body spasms for about 2 hours.  It took me 6 hours until I was finally able to sit up in bed.  Still very weak.  Obviously, I will consult my Dr.
Oval shaped rash developed on or about 6 days after the injection.  Lasted for several days.  Slight itching experienced early on.
Large area of swelling and redness surrounding Injection shot. Area feels hot to touch and is tender. Area has sharp pains periodically.
Patient experienced a seizure after developing a fever in the morning after getting the flu vaccine the evening before. The seizure resolved on its own and the patient recovered without seeking  further medical attention. The mother informed us that the patient  had a seizure a few years ago after developing a high fever.
SkinRash Narrative: Developed localized itch rash at injection site 1 week after vaccine
I had the shot a couple of days ago and did go down like a brick that night and the next day; the injection site is still really red on my arm; very sore; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I had the shot a couple of days ago and did go down like a brick that night and the next day), VACCINATION SITE ERYTHEMA (the injection site is still really red on my arm) and VACCINATION SITE PAIN (very sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (I had the shot a couple of days ago and did go down like a brick that night and the next day), VACCINATION SITE ERYTHEMA (the injection site is still really red on my arm) and VACCINATION SITE PAIN (very sore). At the time of the report, FEELING ABNORMAL (I had the shot a couple of days ago and did go down like a brick that night and the next day) was resolving and VACCINATION SITE ERYTHEMA (the injection site is still really red on my arm) and VACCINATION SITE PAIN (very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
For shot #1 - Pain in left arm where shot was given. For shot #2 - Severe pain in entire body including injection site. Inability to move easily, Headache, Dizziness, Fever of 99.5, Fatigue, Insomnia, Elevated Heart Rate, and Chills
Sever lethargy for three plus weeks.  Loss of apatite , muscle and joint ache.    Second shot , sever lethargy and a repeat of previous symptoms.  Admitted to the ER and spent time in ICU and the hospital for three days .  My blood sugar levels spiked to 1272, and I was diagnosed as Acute Diabetic!  There was no previous signs of Diabetes  and no glucose issues in the past.
3 days after shot, chest pain lasting 3 or more weeks, shortness of breath for 3 weeks, heart palpitations, chest pain, pinching feelings in thighs and inside of biceps, calf cramps lasting 1 month
The first two vaccines were no extreme signs,...just some minor ones like light headed, but after the 3rd vaccine the problems started within the following month.  Reactions likes: shaking, anxiety, chest pain, trouble breathing, confusion, wart outbreak, blood issues (clotting and low oxygen levels) and later Dr's believe she has lupus and Rhuematoid arthritis.  She also just had a fibroma tumor removed from the same foot that had the large wart develop although different area. 10/26/09:  Outpatient medical records received for dates of service 2/6/08 to 10/5/09.  Dx:  Mixed connective tissue disease, Major depressive disorder, Panic disorder with agoraphobia, Pap smear abnormal + HPV, Respiratory abnormality NEC, Anxiety state NOS, Raynaud's syndrome. Assessment:  Presents with persistent arthralgias of the hands and wrists, fatigue and achiness in neck without swelling.  Had positive ANA, placed on Plaquenil.  Also had positive lupus anticoagulant, but a subsequent test was negative.  Started on Methotrexate weekly with positive results.  Left forefoot soft tissue mass excision performed, pt. healing well at 4 weeks post op. Also had episode of hematemesis, and melena, endoscopy was normal.  C/o body shakes, EEG-Abnormal.  Also c/o dyspnea at times, 24 hour Holter monitoring was normal with no correlation between rhythm changes and reported dyspnea.  Tendancy to desat. to 92% with exertion, though treadmill stress test was WNL; started on Advair and albuterol. Pt. has acne vulgaris and peringual warts.  Additional meds.:  Buspirone, Lexapro.
PATIENT CAME TO THE PHARMACY TODAY 04/30/2019 AND SAID HE EXPERIENCED FEVER THE NEXT DAY ALONG WITH SOME MILD SWELLING ON THE ARM WHERE THE SHOT WAS ADMINISTERED. PT WAS INSTRUCTED TO USE BENADRYL OR CORTISONE CREAM OVER THE COUNTER AND COLD ICE PACKS. TODAY 05/02/2019 PATIENT FEELS BETTER AND ALL SYMPTOMS HAVE RESOLVED.
Nausea and vomiting body aches chills headaches night sweats loss of appetite
3 days post the vaccine petechiae found on both legs. Reviewed for 11 days disappearing gradually then tripled higher on legs and now on arms. Aprox 11 days saw another outbreak this time legs and between breast. Continues to have outbreaks.
Patient claimed soreness in Right shoulder of neck after immunization. The next morning had difficulty getting out of bed, took a "pain pill" and felt better. Now is spreading to left side but much less severe.
2 days post vax pt devel redness, swelling around inject site on lt deltoid; Redness area 70 x90mm; No elevated WBC, fever, tenderness;
Tingling in legs, arms and face on same side as vaccine beginning soon after administration, pain in hand. These worsened with time, and fasciculation of the lower lip on same side developed within 24 hours.
nerve pain in my right hand; left arm started to twitch and spasm/twitches all over my body; left arm started to twitch and spasm; fatigue in my legs; This is a spontaneous report from a contactable consumer (patient). A 35-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: Fa7484, expiry date not reported), via an unspecified route of administration, administered in left arm on 26Jul2021 18:00 (at the age of 35 years old) as dose 1, single for covid-19 immunisation. There were no medical history and concomitant medications.  The patient had no covid prior to vaccination. The patient had no known allergies. The patient had no other vaccine in four weeks and no other medications in two weeks. On 07Aug2021 12:15, after vaccination, the patient experienced nerve pain in right hand (neuralgia), left arm started to twitch and spasm, left arm started to twitch and spasm, twitches all over body and fatigue in legs. This was further reported as 2 1/2 weeks after shot, left arm started to twitch and spasm. Over the next two days that grew to twitches all over the body. Patient was still twitching in left arm consistently. Predominately, twitch in belly, legs, and chest, but had twitch in random places in addition to that. Patient was still experiencing fatigue in legs. The events resulted to doctor or other healthcare professional office/clinic visit, and disability or permanent damage. The patient had tested for Covid post vaccination which included nasal swab negative on an unknown date in 2021. No treatments were received in response to the events reported. The outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
10 mins p/vax difficulty breathing, throat felt like it was closing, pale, sweating clammy, wheezing on exam vitals WNL;
more than 42 days for administration of second dose; fever; Chills; weakness in the legs; pain in arm; Around 10 days after second shot, both husband and wife experienced pain in the low back; She has trouble walking and sitting down; This spontaneous case was reported by a patient and describes the occurrence of BACK PAIN (Around 10 days after second shot, both husband and wife experienced pain in the low back), MOBILITY DECREASED (She has trouble walking and sitting down), MUSCULAR WEAKNESS (weakness in the legs), PAIN IN EXTREMITY (pain in arm) and PYREXIA (fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027HIB and 004D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included IBUPROFEN for Low back pain.   On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Dec-2021, the patient experienced MUSCULAR WEAKNESS (weakness in the legs), PYREXIA (fever) and CHILLS (Chills). On 12-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 42 days for administration of second dose). In December 2021, the patient experienced BACK PAIN (Around 10 days after second shot, both husband and wife experienced pain in the low back), MOBILITY DECREASED (She has trouble walking and sitting down) and PAIN IN EXTREMITY (pain in arm). On 05-Dec-2021, MUSCULAR WEAKNESS (weakness in the legs), PYREXIA (fever) and CHILLS (Chills) had resolved. On 12-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 42 days for administration of second dose) had resolved. In December 2021, PAIN IN EXTREMITY (pain in arm) had resolved. At the time of the report, BACK PAIN (Around 10 days after second shot, both husband and wife experienced pain in the low back) had not resolved and MOBILITY DECREASED (She has trouble walking and sitting down) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medication also includes Anti-inflammatory medication for Low back pain
Welt-like red mark by injection site (right leg) 10 days after vaccination. Second smaller red mark on day 11.
10 minutes after receiving vaccine, patient reported numbness across upper lip which progressed to her tongue. Felt tingling and dryness of tongue and swelling. No difficulty breathing or swallowing, no chest pain, no wheezing, no rash, no itching. Taken to ED and given methylprednisolone 125mg IV, diphenhydramine 50mg IV, famotidine 20mg PO. Patient improved and monitored x 4 hours with resolution of symptoms. Prescribed prednisone 50mg po x 4 days.
Difficulty breathing through nose.  Took to urgent care facility on 10/25/2015 although should have taken him 10/24/15.  Doctor prescribed oral steroids to decrease swelling from reaction to the nasal vaccine.
LL with redness approx. 2 cm in diameter after Proquad 0.5 mL SQ.
Mom reports seizure activity at home around 6 pm. Mom did not notice anything that stood out from his normal behavior. Paramedic's were called post seizure activity and child was checked out to be stable with a fever of 102.
She contracted COVID-19 on 06/06/2022 with symptoms of fever, fatigue, congestion, runny nose, cough, myalgia, and chills. She was given TYLENOL, ibuprofen, and BENADRYL, and was not prescribed any medications by her doctor. Her symptoms began to resolve on 06/12/2022, but she is not yet fully recovered.
Petechiae vascular; This spontaneous case was reported by a health care professional and describes the occurrence of PETECHIAE (Petechiae vascular) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jan-2021, the patient experienced PETECHIAE (Petechiae vascular). At the time of the report, PETECHIAE (Petechiae vascular) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter. Concomitant product use was not provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This spontaneous report was received from an office manager and refers to an 18 year old patient of unknown gender. The patient's concurrent conditions, medical history and drug reactions or allergies were not reported. On an unknown date, the patient was inadvertently vaccinated with Oka-Merck PROQUAD lot # N019826, expiration date 09-JAN-2019 (route, dose and frequency were not reported) for prophylaxis (Drug administered to patient of inappropriate age) along with an sterile diluent. No adverse effects were reported. No product quality complaint (PQC) was involved.
THE PATIENT FELL BECAUSE SHE FELT DIZZY. HER BLOOD PRESSURE WAS 165/110 AND CAME DOWN TO 91/72.
Pfizer-BioNTech Covid-19 Vaccine EUA  10 minutes post vaccine my heart started racing, felt light headed and weak, chills with body shakes, unable to clear throat. 30 minutes post vaccine heart pounding and racing off and on, elevated blood pressure, chills and shaking, weakness all over. Went to the ER. Was told ECG was normal, blood pressure was high and pulse was high. Discharged with a diagnosis of palpitations and and adverse reaction to covid vaccine.
Swollen Face, Lips, Muscle pain, Nausea, and Shivering
After my 3rd dose I was diagnosed with diabetes. I got really sick and started diabetes medications.
1 1/2 hrs p/receiving vax started shaking, eyes rolled back in head & skin turned bluish; pt seen in ER; pt is 15% behind developmentally since birth;
Employee develop redness, hardness, swollen, warm to touch area 2 - 3 inches below injection site of flu vaccine in right upper arm on 10/16/13. 10/18/13 went to ED - itchiness, redness and hardness and weeping. BACTRIM x 10 days and steroids x 10 days order for cellulitis. 10/19 area improving.
pt recv vax 24SEP97 & 1PM mild progressing to uncomfortable stinging began by 3PM;rt arm immobile, swollen by 1AM;syncope x 30sec;T103 tx w/ASA redness from arm to shoulder & neck area 7AM;T100.0 by 8AM;
Patient received FLUVIRIN at 14:15 on 9/17/09. Called on 9/18/09 to report she had dizziness and shortness of breath. Told her son to take her to see physician.
serious neurological problems; painful blistering rash; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 21-JUL-2015, the patient was inoculated with the zoster vaccine live (ZOSTAVAX) (lot number, dosage, and route of administration not provided) for the long-term prevention of shingles and zoster-related conditions. Subsequently (date not reported), the patient was treated by a provider for the following injuries resulting from zoster vaccine live (ZOSTAVAX) use: painful blistering rash and serious neurological problems. The outcome of the events was not reported. The events were considered to be related to zoster vaccine live (ZOSTAVAX).
Periodic feelings of fever (hot) in head, torso, arms but no high temperature detected with scan thermometer. The feeling lasts for about an hour or so. It happens at least once a week.
Patient had slight queasiness/stomach discomfort and slight blurry vision before administration of vaccine. Both intensified within a couple minutes after vaccination, and 5 minutes after administration patient fainted/lost consciousness. He regained consciousness 10 seconds later and was ambulatory afterwards. Patient exhibited no difficulty of breath or cognitive impairment. Pharmacist had patient sit and drink water for a half-hour afterwards with observation. Patient left store on own ability and left afterwards.
day 11 itching all over swollen hands & behind ears + jaw line;arthritic like pain-all joints;rash-small hives on hips & elbow;took DPH w/some relief;day 12 all of above sx + swollen lips &  hives around inj site;t99.9;malaise;
According to patient, rash with a few spots appeared on 05/26/2012 with a few spots on face.  On 05/28/2012 he was feeling ill and lethargy or "not just right"  Also complained of "night sweats".  TSTs were negative in the past.  Rash on back and upper chest and a 1" x 1 1/2 " reddened, elevated area with oozing and itching noted on 05/30/2012.
Got the vaccine on 3/30/21 and about 1.5 week later got almost complete blindness in the right eye. Went to see Dr.  he determined a blood clot in that right eye. Six hours later, the blood clot dissolved on its own. Was told to take Aspirin 81 mg daily.
Medication error: first dosage of Moderna Covid Vaccine 0.5 cc given to patient under 18 years of age (17 years old). No complaints or adverse reactions noted.  Parent (EMT) contacted & advised to observe for any adverse reaction, if any.
covid vaccine breakthrough case   dose 1 Pfizer 5/5/21 EW0175 dose 2 Pfizer 5/26/21 EW0183
Acute decrease in vision clarity 6 months after 1 dose of SHINGRIX. Pt has not received 2nd dose. Pt states that she would guess that her vision as decreased by 20% in the last month, requiring more light and magnification. She has not been evaluated by a specialist yet, but has an appointment to investigate her concerns.
Reaction at Pneumovax injection site.  Raised redness at injection site: 1-2 inch circumference from site of injection right arm (deltoid).  Warm to touch
Swelling of the injection site, three days later big painful lump on the Left auxiliary , swollen lymph node, the size of the about an inch in diameter.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history and concomitant therapies were not reported. On an unknown date, the patient was inadvertently vaccinated with a dose of VAQTA (dose, lot #, expiration date and route were not reported) for prophylaxis; when the patient should have received RECOMBIVAX HB. No adverse symptoms reported.
PSA higher than normal; This spontaneous case was reported by a consumer and describes the occurrence of PROSTATIC SPECIFIC ANTIGEN INCREASED (PSA higher than normal) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Previously administered products included for Prostate cancer: lupron injection (Patient took lupron injection for prostate cancer) on 07-Jan-2021.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 26-Apr-2021, the patient experienced PROSTATIC SPECIFIC ANTIGEN INCREASED (PSA higher than normal). At the time of the report, PROSTATIC SPECIFIC ANTIGEN INCREASED (PSA higher than normal) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Prostatic specific antigen: increased (High) Lupron shot normally brings Patient's PSA to around 0.8 and Patient went back today for next lupron injection and PSA was 1.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications were not provided by reporter.  Treatment medications were not given.   This case was linked to MOD-2021-020239 (Patient Link).
This case was reported by a consumer via call center representative and described the occurrence of light headedness in a female patient who received Shingrix for prophylaxis. In July 2018, the patient received the 1st dose of Shingrix (intramuscular). In July 2018, immediately after receiving Shingrix, the patient experienced light headedness, tiredness and pain in arm. On an unknown date, the outcome of the light headedness, tiredness and pain in arm were recovered/resolved. It was unknown if the reporter considered the light headedness, tiredness and pain in arm to be related to Shingrix. Additional information was reported as follows: The batch number for Shingrix was not reported. In July 2018 at 12:00, exactly two months before the date of reporting, the patient was vaccinated with the 1st dose of Shingrix. Less than a day after vaccination with Shingrix, the patient experienced pain in arm. One day after vaccination with Shingrix, the patient felt extremely tired and it lasted for a week to a week and a half before resolving. The patient experienced extreme arm soreness, which lasted for a week. The patient's husband experienced the same symptoms, in the same time frame.  This case was linked to case US2018165509 (husband case), reported by the same reporter.
Pt received 1 Pfizer booster vaccine  after having had 3 Moderna vaccines.  Pt denied complaints  after 15 mins. HCP encouraged pt and husband to seek medical attention for symptoms difficult to manage at home. Pt. left clinic w/o complaints  and with husband.  HCP called pt (and Husband) to check on pt and husband and was unsuccesful reaching them.  Left message to call me with concerns and questions.
feet turning yellow; This spontaneous case was reported by a consumer and describes the occurrence of YELLOW SKIN (feet turning yellow) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced YELLOW SKIN (feet turning yellow). On 07-Mar-2021, YELLOW SKIN (feet turning yellow) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The  concomitant medications on use were not provided. No laboratory data was provided.  No treatment information was provided.